The University of Southampton
University of Southampton Institutional Repository

Outcome of hospitalization for COVID-19 in Patients with Interstitial Lung Disease: an International Multicenter Study

Outcome of hospitalization for COVID-19 in Patients with Interstitial Lung Disease: an International Multicenter Study
Outcome of hospitalization for COVID-19 in Patients with Interstitial Lung Disease: an International Multicenter Study

Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established.Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population.Methods: An international multicenter audit of patients with a prior diagnosis of ILD admitted to the hospital with COVID-19 between March 1 and May 1, 2020, was undertaken and compared with patients without ILD, obtained from the ISARIC4C (International Severe Acute Respiratory and Emerging Infection Consortium Coronavirus Clinical Characterisation Consortium) cohort, admitted with COVID-19 over the same period. The primary outcome was survival. Secondary analysis distinguished idiopathic pulmonary fibrosis from non-idiopathic pulmonary fibrosis ILD and used lung function to determine the greatest risks of death.Measurements and Main Results: Data from 349 patients with ILD across Europe were included, of whom 161 were admitted to the hospital with laboratory or clinical evidence of COVID-19 and eligible for propensity score matching. Overall mortality was 49% (79/161) in patients with ILD with COVID-19. After matching, patients with ILD with COVID-19 had significantly poorer survival (hazard ratio [HR], 1.60; confidence interval, 1.17-2.18; P = 0.003) than age-, sex-, and comorbidity-matched controls without ILD. Patients with an FVC of <80% had an increased risk of death versus patients with FVC ≥80% (HR, 1.72; 1.05-2.83). Furthermore, obese patients with ILD had an elevated risk of death (HR, 2.27; 1.39-3.71).Conclusions: Patients with ILD are at increased risk of death from COVID-19, particularly those with poor lung function and obesity. Stringent precautions should be taken to avoid COVID-19 in patients with ILD.

COVID-19, idiopathic pulmonary fibrosis, interstitial lung disease, lung function, obesity
1073-449X
1656-1665
Drake, Thomas M.
059a4d12-8b2d-449a-87d6-f59e00786557
Docherty, Annemarie B.
0b579461-1b7a-456a-aa13-09f229c7a9d8
Harrison, Ewen M.
6e9fdc8e-928d-4135-b8d1-9547783025f1
Quint, Jennifer K.
22800655-8987-4464-8385-7f08860c92f9
Adamali, Huzaifa
488339d5-0b2b-47b7-adec-bf3c6b039be3
Agnew, Sarah
3b2e34da-51df-4727-8c0b-f317742f2985
Babu, Suresh
c0483a6f-0d41-4337-be65-5acff7920a40
Barber, Christopher M
cd194db2-f606-46ec-9881-96ded96c2a1d
Barratt, Shaney
3ab04f7e-99c2-43d6-ae74-d2646528e998
Bendstrup, Elisabeth
e1ab7d06-ab38-4391-a107-9004bdc84609
Bianchi, Stephen
246de43f-77dc-4f2a-9587-011a5f2b97f2
Castillo Villegas, Diego
acf4d630-e4bd-49c4-8a57-2f5a93e2193a
Chaudhuri, Nazia
21496f8d-8b7b-4275-ac86-7a494871c9e1
Chua, Felix
555a3d30-6197-4d1f-a1f5-f6ca292f3f30
Coker, Robina
574cd215-5ceb-43d3-b4d4-393b13c7d3f5
Chang, William
09bde6f3-e81e-4e08-9831-74d928fb3e8e
Crawshaw, Anjali
5580d94e-2830-4e56-bfb7-d4af353bbe8d
Crowley, Louise E.
0a1fbec6-f731-4e80-8e62-90606d4a72e1
Dosanjh, Davinder
41a07f95-7258-4084-8a30-37fcdc1073f5
Fiddler, Christine A.
11040a7e-7da8-4c65-80db-5e9359cbb6c9
Forrest, Ian A.
f8cd16e0-2a00-4cf6-ae07-b9e2c53f1a10
George, Peter M.
4145ec98-655f-419c-8773-4bedfc7a67e8
Gibbons, Michael A.
e5231df8-d0bc-4cb6-9a8e-a1bf5882ae9e
Groom, Katherine
0c6b581a-f6f7-4726-9147-9d3764437d20
Haney, Sarah
f91bc1c0-9440-4262-95e5-f5c29ea39e0b
Hart, Simon P.
ad94068b-8bdb-4f82-86cf-365e638fb607
Heiden, Emily
2921110b-b184-4e61-8633-116b1b8129cc
Henry, Michael
b25e1710-087b-410f-b010-3b9352264c79
Ho, Ling-Pei
78fd2483-d7c2-4244-8ffe-e3c8a2d27e32
Hoyles, Rachel K.
0cc27739-be35-4907-ac26-a604500d98d5
Hutchinson, John
f1b2487d-a4af-45b1-985f-44f1829d4a94
Hurley, Killian
b852527c-8203-4bef-bfcc-febb3a82e8ea
Jones, Mark G.
a6fd492e-058e-4e84-a486-34c6035429c1
Kreuter, Michael
f97455b8-d063-4e97-b0d2-c8bc715d04a2
Mahendran, Siva
310c2afd-18f0-4b27-af14-32b1ba0d1708
Margaritopoulos, George
755c510d-f383-4903-9fcd-49c090a836d1
Molina-Molina, Maria
b981837d-464d-4374-91f1-15af7451e0ce
Molyneaux, Philip L
9761b4a9-5539-4683-a023-af7e351365ee
Parfrey, Helen
4218ef5d-db8d-4383-af21-036efc3f0887
Porter, Joanna C.
81de36d2-271c-4846-a8e9-69482df329b2
Renzoni, Elisabetta
31d75135-b9e3-4071-9d8f-37c07495e62f
Rivera-Ortega, Pilar
6319eb89-7631-4990-ab08-29d8908cb4be
Jenkins, Gisli R.
4066b42c-38c4-40b8-baec-a0ca0352189b
Dushianthan, Ahilanandan
013692a2-cf26-4278-80bd-9d8fcdb17751
ISARIC4C Investigators
Drake, Thomas M.
059a4d12-8b2d-449a-87d6-f59e00786557
Docherty, Annemarie B.
0b579461-1b7a-456a-aa13-09f229c7a9d8
Harrison, Ewen M.
6e9fdc8e-928d-4135-b8d1-9547783025f1
Quint, Jennifer K.
22800655-8987-4464-8385-7f08860c92f9
Adamali, Huzaifa
488339d5-0b2b-47b7-adec-bf3c6b039be3
Agnew, Sarah
3b2e34da-51df-4727-8c0b-f317742f2985
Babu, Suresh
c0483a6f-0d41-4337-be65-5acff7920a40
Barber, Christopher M
cd194db2-f606-46ec-9881-96ded96c2a1d
Barratt, Shaney
3ab04f7e-99c2-43d6-ae74-d2646528e998
Bendstrup, Elisabeth
e1ab7d06-ab38-4391-a107-9004bdc84609
Bianchi, Stephen
246de43f-77dc-4f2a-9587-011a5f2b97f2
Castillo Villegas, Diego
acf4d630-e4bd-49c4-8a57-2f5a93e2193a
Chaudhuri, Nazia
21496f8d-8b7b-4275-ac86-7a494871c9e1
Chua, Felix
555a3d30-6197-4d1f-a1f5-f6ca292f3f30
Coker, Robina
574cd215-5ceb-43d3-b4d4-393b13c7d3f5
Chang, William
09bde6f3-e81e-4e08-9831-74d928fb3e8e
Crawshaw, Anjali
5580d94e-2830-4e56-bfb7-d4af353bbe8d
Crowley, Louise E.
0a1fbec6-f731-4e80-8e62-90606d4a72e1
Dosanjh, Davinder
41a07f95-7258-4084-8a30-37fcdc1073f5
Fiddler, Christine A.
11040a7e-7da8-4c65-80db-5e9359cbb6c9
Forrest, Ian A.
f8cd16e0-2a00-4cf6-ae07-b9e2c53f1a10
George, Peter M.
4145ec98-655f-419c-8773-4bedfc7a67e8
Gibbons, Michael A.
e5231df8-d0bc-4cb6-9a8e-a1bf5882ae9e
Groom, Katherine
0c6b581a-f6f7-4726-9147-9d3764437d20
Haney, Sarah
f91bc1c0-9440-4262-95e5-f5c29ea39e0b
Hart, Simon P.
ad94068b-8bdb-4f82-86cf-365e638fb607
Heiden, Emily
2921110b-b184-4e61-8633-116b1b8129cc
Henry, Michael
b25e1710-087b-410f-b010-3b9352264c79
Ho, Ling-Pei
78fd2483-d7c2-4244-8ffe-e3c8a2d27e32
Hoyles, Rachel K.
0cc27739-be35-4907-ac26-a604500d98d5
Hutchinson, John
f1b2487d-a4af-45b1-985f-44f1829d4a94
Hurley, Killian
b852527c-8203-4bef-bfcc-febb3a82e8ea
Jones, Mark G.
a6fd492e-058e-4e84-a486-34c6035429c1
Kreuter, Michael
f97455b8-d063-4e97-b0d2-c8bc715d04a2
Mahendran, Siva
310c2afd-18f0-4b27-af14-32b1ba0d1708
Margaritopoulos, George
755c510d-f383-4903-9fcd-49c090a836d1
Molina-Molina, Maria
b981837d-464d-4374-91f1-15af7451e0ce
Molyneaux, Philip L
9761b4a9-5539-4683-a023-af7e351365ee
Parfrey, Helen
4218ef5d-db8d-4383-af21-036efc3f0887
Porter, Joanna C.
81de36d2-271c-4846-a8e9-69482df329b2
Renzoni, Elisabetta
31d75135-b9e3-4071-9d8f-37c07495e62f
Rivera-Ortega, Pilar
6319eb89-7631-4990-ab08-29d8908cb4be
Jenkins, Gisli R.
4066b42c-38c4-40b8-baec-a0ca0352189b
Dushianthan, Ahilanandan
013692a2-cf26-4278-80bd-9d8fcdb17751

Drake, Thomas M., Docherty, Annemarie B., Harrison, Ewen M., Quint, Jennifer K., Adamali, Huzaifa, Agnew, Sarah, Babu, Suresh, Barber, Christopher M, Barratt, Shaney, Bendstrup, Elisabeth, Bianchi, Stephen, Castillo Villegas, Diego, Chaudhuri, Nazia, Chua, Felix, Coker, Robina, Chang, William, Crawshaw, Anjali, Crowley, Louise E., Dosanjh, Davinder, Fiddler, Christine A., Forrest, Ian A., George, Peter M., Gibbons, Michael A., Groom, Katherine, Haney, Sarah, Hart, Simon P., Heiden, Emily, Henry, Michael, Ho, Ling-Pei, Hoyles, Rachel K., Hutchinson, John, Hurley, Killian, Jones, Mark G., Kreuter, Michael, Mahendran, Siva, Margaritopoulos, George, Molina-Molina, Maria, Molyneaux, Philip L, Parfrey, Helen, Porter, Joanna C., Renzoni, Elisabetta, Rivera-Ortega, Pilar and Jenkins, Gisli R. , ISARIC4C Investigators (2020) Outcome of hospitalization for COVID-19 in Patients with Interstitial Lung Disease: an International Multicenter Study. American Journal of Respiratory and Critical Care Medicine, 202 (12), 1656-1665. (doi:10.1164/rccm.202007-2794OC).

Record type: Article

Abstract

Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established.Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population.Methods: An international multicenter audit of patients with a prior diagnosis of ILD admitted to the hospital with COVID-19 between March 1 and May 1, 2020, was undertaken and compared with patients without ILD, obtained from the ISARIC4C (International Severe Acute Respiratory and Emerging Infection Consortium Coronavirus Clinical Characterisation Consortium) cohort, admitted with COVID-19 over the same period. The primary outcome was survival. Secondary analysis distinguished idiopathic pulmonary fibrosis from non-idiopathic pulmonary fibrosis ILD and used lung function to determine the greatest risks of death.Measurements and Main Results: Data from 349 patients with ILD across Europe were included, of whom 161 were admitted to the hospital with laboratory or clinical evidence of COVID-19 and eligible for propensity score matching. Overall mortality was 49% (79/161) in patients with ILD with COVID-19. After matching, patients with ILD with COVID-19 had significantly poorer survival (hazard ratio [HR], 1.60; confidence interval, 1.17-2.18; P = 0.003) than age-, sex-, and comorbidity-matched controls without ILD. Patients with an FVC of <80% had an increased risk of death versus patients with FVC ≥80% (HR, 1.72; 1.05-2.83). Furthermore, obese patients with ILD had an elevated risk of death (HR, 2.27; 1.39-3.71).Conclusions: Patients with ILD are at increased risk of death from COVID-19, particularly those with poor lung function and obesity. Stringent precautions should be taken to avoid COVID-19 in patients with ILD.

Text
Final Outcome of COVID-19 merged in ILD For Submission - Accepted Manuscript
Download (556kB)

More information

Accepted/In Press date: 2 October 2020
e-pub ahead of print date: 2 October 2020
Published date: 15 December 2020
Keywords: COVID-19, idiopathic pulmonary fibrosis, interstitial lung disease, lung function, obesity

Identifiers

Local EPrints ID: 444335
URI: http://eprints.soton.ac.uk/id/eprint/444335
ISSN: 1073-449X
PURE UUID: daf45f18-be02-4e69-b06c-965025b81d02
ORCID for Mark G. Jones: ORCID iD orcid.org/0000-0001-6308-6014
ORCID for Ahilanandan Dushianthan: ORCID iD orcid.org/0000-0002-0165-3359

Catalogue record

Date deposited: 13 Oct 2020 16:43
Last modified: 08 Oct 2024 04:02

Export record

Altmetrics

Contributors

Author: Thomas M. Drake
Author: Annemarie B. Docherty
Author: Ewen M. Harrison
Author: Jennifer K. Quint
Author: Huzaifa Adamali
Author: Sarah Agnew
Author: Suresh Babu
Author: Christopher M Barber
Author: Shaney Barratt
Author: Elisabeth Bendstrup
Author: Stephen Bianchi
Author: Diego Castillo Villegas
Author: Nazia Chaudhuri
Author: Felix Chua
Author: Robina Coker
Author: William Chang
Author: Anjali Crawshaw
Author: Louise E. Crowley
Author: Davinder Dosanjh
Author: Christine A. Fiddler
Author: Ian A. Forrest
Author: Peter M. George
Author: Michael A. Gibbons
Author: Katherine Groom
Author: Sarah Haney
Author: Simon P. Hart
Author: Emily Heiden
Author: Michael Henry
Author: Ling-Pei Ho
Author: Rachel K. Hoyles
Author: John Hutchinson
Author: Killian Hurley
Author: Mark G. Jones ORCID iD
Author: Michael Kreuter
Author: Siva Mahendran
Author: George Margaritopoulos
Author: Maria Molina-Molina
Author: Philip L Molyneaux
Author: Helen Parfrey
Author: Joanna C. Porter
Author: Elisabetta Renzoni
Author: Pilar Rivera-Ortega
Author: Gisli R. Jenkins
Author: Ahilanandan Dushianthan ORCID iD
Corporate Author: ISARIC4C Investigators

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×